Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity
نویسندگان
چکیده
To elucidate clinical trial efficacy, safety, and dosing practices of AbobotulinumtoxinA (ABO) treatment in adult patients with lower limb spasticity.A systematic literature review was performed to identify randomized controlled trials of ABO in the treatment of adult lower limb spasticity.Of the 295 records identified, 6 primary publications evaluated ABO for the management of lower limb spasticity of various etiologies and were evaluated. Total ABO doses ranged between 500 and 2000 U for lower limb spasticity, depending on the muscles injected. All studies in lower limb spasticity showed statistically significant reduction in muscle tone based on Modified Ashworth Scale of ABO versus placebo. Significant effects on active movement and pain were demonstrated albeit less consistently. ABO was generally well tolerated across the individual studies; most adverse events reported were considered unrelated to treatment. Treatment-related adverse events included but not limited to fatigue, local pain at injection site, hypertonia, dry mouth, weakness of the noninjected muscle, abnormal gait, and urinary tract infection.These data from 6 randomized clinical studies provide the beginnings of an evidence base for the use of ABO to reduce lower limb spasticity. Ongoing studies in this area will add to this evidence base.
منابع مشابه
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Adult Upper Limb Spasticity
OBJECTIVE The aim of this study was to elucidate clinical trial efficacy, safety, and dosing practices of abobotulinumtoxinA (ABO) treatment in adult patients with upper limb spasticity (ULS). METHODS A systematic literature review was performed to identify randomized controlled trials and other comparative clinical studies of ABO in the treatment of adult ULS published in English between Jan...
متن کاملBudget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
BACKGROUND Botulinum toxin A (BoNT-A) is an effective treatment for patients with upper limb spasticity (ULS), which is a debilitating feature of upper motor neuron lesions. BoNT-A preparations available in the UK are associated with different costs. METHODS We developed a budget impact model to assess the effect of changing market shares of different BoNT-A formulations - abobotulinumtoxinA,...
متن کاملOnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review
BACKGROUND OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for treatment of adult spasticity, as reported in published studies. METHODS A systematic review of clinical trials and observational studies published between 1990 and 2011 reporting data on muscles i...
متن کاملSafety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy
This was a prospective, repeat-treatment, open-label study (NCT01251380) of abobotulinumtoxinA for the management of lower limb spasticity in children who had completed a double-blind study. Children (2-17 years) received injections into the gastrocnemius-soleus complex, and other distal and proximal muscles as required (maximum total dose per injection cycle: 30 U/kg or 1000U). A total of 216 ...
متن کاملDistal Approaches in Patellofemoral Pain: A Systematic Review, Part I
Purpose: Increased patellofemoral joint reaction force (PFJRF) is the main cause of patellofemoral pain syndrome (PFP). Foot pronation causes faulty joint coupling of the lower limb and increases the PFJRF. Therefore, the aim of systematic review is effect of the distal interventions on the clinical symptoms and kinematic of PFP patients. Methods: The search strategy was carried out from Goo...
متن کامل